Top News

Amgen, Illumina In Diagnostic Test Deal




Thousand Oaks-based Amgen and San Diego-based Illumina are in an agreement to develop and commercialize a test for metastatic colorectal cancer, Illumina said late Wednesday. Illumina said the test will use its MiSeqDx instrument to develop a test platform which can identify patients who would be appropriate to receive Vectibix, Amgen's anti-EGFR monocolonal antibody--which is used for treating colorectal cancer. Financial terms of the deal were not disclosed.


 

Marketplace


 

 

Latest Headlines

Browse Issues

 
 

Keep up with all of the latest Southern California high tech news via email (it's free!)



or Cancel